Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Vascular Dementia | Research article

Moderately increased albuminuria, chronic kidney disease and incident dementia: the HUNT study

Authors: Jessica Mira Gabin, Solfrid Romundstad, Ingvild Saltvedt, Jostein Holmen

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

Epidemiologic studies has shown an association of albuminuria and low estimated glomerular filtration rate (eGFR) with dementia, but the findings are inconsistent. This study examines the association between eGFR, MA with dementia and its subtypes: AD, VaD, a mixture of AD/VaD, and other dementias.

Methods

Data from the second wave of the HUNT 2 Study (1995–1997) were linked with a dementia register known as the Health and Memory Study (HMS) collected during 1995–2011 in Nord-Trøndelag County, Norway. Dementia was ascertained using World Health Organization’s ICD-10 criteria into subtypes: AD,VaD, mixed AD/VaD, and other dementia. eGFR and its association with dementia was examined in 48,508 participants of the HUNT Study, of which 668 were diagnosed with all-cause dementia. Association between MA and dementia were studied in a subset of 7024 participants, and 214 were diagnosed with all-cause dementia. Cox regression models were conducted analyzing the association between dementia and MA using albumin creatine ratio (ACR). Cox regression models and Fine-Gray models were used to examine the association between dementia and eGFR.

Results

A positive association was found between increasing ACR and dementia. ACR in the fourth quartile (> 1.78 mg/mmol) with increased hazard ratio of VaD, 3.97 (1.12 to 14.07), compared with ACR in the first quartile (<.53 mg/mmol). There was no association between eGFR and dementia or its subgroups.

Conclusions

Our results strengthens the hypothesis that vascular mechanisms may affect both kidney and brain as an association between MA and dementia was found. However, eGFR was not significantly associated with dementia independent of diabetes mellitus or hypertension.
Appendix
Available only for authorised users
Literature
1.
go back to reference Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673–734.PubMedCrossRef Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673–734.PubMedCrossRef
2.
3.
go back to reference Nagasawa T, Mori T, Ohsaki Y, et al. Albuminuria indicates the pressure-associated injury of juxtamedullary nephrons and cerebral strain vessels in spontaneously hypertensive stroke-prone rats. Hypertens Res. 2012;35(10):1024–31.PubMedPubMedCentralCrossRef Nagasawa T, Mori T, Ohsaki Y, et al. Albuminuria indicates the pressure-associated injury of juxtamedullary nephrons and cerebral strain vessels in spontaneously hypertensive stroke-prone rats. Hypertens Res. 2012;35(10):1024–31.PubMedPubMedCentralCrossRef
4.
go back to reference Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72.PubMedCrossRef Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72.PubMedCrossRef
5.
go back to reference Kurella Tamura M, Yaffe K. Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies. Kidney Int. 2011;79(1):14–22.PubMedCrossRef Kurella Tamura M, Yaffe K. Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies. Kidney Int. 2011;79(1):14–22.PubMedCrossRef
6.
go back to reference Weiner DE, Gaussoin SA, Nord J, et al. Cognitive function and kidney disease: baseline data from the systolic blood pressure intervention trial (SPRINT). Am J kidney Dis. 2017;70(3):357–67.PubMedPubMedCentralCrossRef Weiner DE, Gaussoin SA, Nord J, et al. Cognitive function and kidney disease: baseline data from the systolic blood pressure intervention trial (SPRINT). Am J kidney Dis. 2017;70(3):357–67.PubMedPubMedCentralCrossRef
7.
go back to reference Zammit AR, Katz MJ, Bitzer M, Lipton RB. Cognitive impairment and dementia in older adults with chronic kidney disease: a review. Alzheimer Dis Assoc Disord. 2016;30(4):357–66.PubMedPubMedCentralCrossRef Zammit AR, Katz MJ, Bitzer M, Lipton RB. Cognitive impairment and dementia in older adults with chronic kidney disease: a review. Alzheimer Dis Assoc Disord. 2016;30(4):357–66.PubMedPubMedCentralCrossRef
8.
go back to reference Deckers K, Camerino I, van Boxtel MP, et al. Dementia risk in renal dysfunction: a systematic review and meta-analysis of prospective studies. Neurology. 2017;88(2):198–208.PubMedPubMedCentralCrossRef Deckers K, Camerino I, van Boxtel MP, et al. Dementia risk in renal dysfunction: a systematic review and meta-analysis of prospective studies. Neurology. 2017;88(2):198–208.PubMedPubMedCentralCrossRef
9.
go back to reference Barzilay JI, Gao P, O'Donnell M, et al. Albuminuria and decline in cognitive function: the ONTARGET/TRANSCEND studies. Arch Intern Med. 2011;171(2):142–50.PubMedCrossRef Barzilay JI, Gao P, O'Donnell M, et al. Albuminuria and decline in cognitive function: the ONTARGET/TRANSCEND studies. Arch Intern Med. 2011;171(2):142–50.PubMedCrossRef
10.
go back to reference Takae K, Hata J, Ohara T, et al. Albuminuria increases the risks for both Alzheimer disease and vascular dementia in community-dwelling Japanese elderly: the Hisayama study. J Am Heart Assoc. 2018;7(2):e006693.PubMedPubMedCentralCrossRef Takae K, Hata J, Ohara T, et al. Albuminuria increases the risks for both Alzheimer disease and vascular dementia in community-dwelling Japanese elderly: the Hisayama study. J Am Heart Assoc. 2018;7(2):e006693.PubMedPubMedCentralCrossRef
11.
go back to reference Helmer C, Stengel B, Metzger M, et al. Chronic kidney disease, cognitive decline, and incident dementia: the 3C study. Neurology. 2011;77(23):2043–51.PubMedCrossRef Helmer C, Stengel B, Metzger M, et al. Chronic kidney disease, cognitive decline, and incident dementia: the 3C study. Neurology. 2011;77(23):2043–51.PubMedCrossRef
12.
13.
go back to reference Seliger SL, Wendell CR, Waldstein SR, Ferrucci L, Zonderman AB. Renal function and long-term decline in cognitive function: the Baltimore longitudinal study of aging. Am J Nephrol. 2015;41(4–5):305–12.PubMedCrossRef Seliger SL, Wendell CR, Waldstein SR, Ferrucci L, Zonderman AB. Renal function and long-term decline in cognitive function: the Baltimore longitudinal study of aging. Am J Nephrol. 2015;41(4–5):305–12.PubMedCrossRef
14.
go back to reference Seliger SL, Siscovick DS, Stehman-Breen CO, et al. Moderate renal impairment and risk of dementia among older adults: the cardiovascular health cognition study. J Am Soc Nephrol. 2004;15(7):1904–11.PubMedCrossRef Seliger SL, Siscovick DS, Stehman-Breen CO, et al. Moderate renal impairment and risk of dementia among older adults: the cardiovascular health cognition study. J Am Soc Nephrol. 2004;15(7):1904–11.PubMedCrossRef
15.
go back to reference Hallan H, Romundstad S, Kvenild K, Holmen J. Microalbuminuria in diabetic and hypertensive patients and the general population--consequences of various diagnostic criteria--the Nord-Trondelag health study (HUNT). Scand J Urol Nephrol. 2003;37(2):151–8.PubMedCrossRef Hallan H, Romundstad S, Kvenild K, Holmen J. Microalbuminuria in diabetic and hypertensive patients and the general population--consequences of various diagnostic criteria--the Nord-Trondelag health study (HUNT). Scand J Urol Nephrol. 2003;37(2):151–8.PubMedCrossRef
16.
go back to reference Knopman DS. Invited commentary: albuminuria and microvascular disease of the brain--a shared pathophysiology. Am J Epidemiol. 2010;171(3):287–9 author reply 90-1.PubMedPubMedCentralCrossRef Knopman DS. Invited commentary: albuminuria and microvascular disease of the brain--a shared pathophysiology. Am J Epidemiol. 2010;171(3):287–9 author reply 90-1.PubMedPubMedCentralCrossRef
17.
go back to reference Krokstad S, Langhammer A, Hveem K, et al. Cohort profile: the HUNT study. Int J Epidemiol. 2012;42(4):968–77.PubMedCrossRef Krokstad S, Langhammer A, Hveem K, et al. Cohort profile: the HUNT study. Int J Epidemiol. 2012;42(4):968–77.PubMedCrossRef
18.
go back to reference Holmen J, Midthjell K, Krüger Ø, et al. The Nord-Trøndelag health study 1995-97 (HUNT 2): objectives, contents, methods and participation. Norsk Epidemiologi. 2003;13(1):19–32. Holmen J, Midthjell K, Krüger Ø, et al. The Nord-Trøndelag health study 1995-97 (HUNT 2): objectives, contents, methods and participation. Norsk Epidemiologi. 2003;13(1):19–32.
19.
go back to reference Bergh S, Holmen J, Gabin J, et al. Cohort profile: the health and memory study (HMS): a dementia cohort linked to the HUNT study in Norway. Int J Epidemiol. 2014;43(6):1759–68.PubMedCrossRef Bergh S, Holmen J, Gabin J, et al. Cohort profile: the health and memory study (HMS): a dementia cohort linked to the HUNT study in Norway. Int J Epidemiol. 2014;43(6):1759–68.PubMedCrossRef
20.
go back to reference Prinz N, Stingl J, Dapp A, et al. High rate of hypoglycemia in 6770 type 2 diabetes patients with comorbid dementia: a multicenter cohort study on 215,932 patients from the German/Austrian diabetes registry. Diabetes Res Clin Pract. 2016;112:73–81.PubMedCrossRef Prinz N, Stingl J, Dapp A, et al. High rate of hypoglycemia in 6770 type 2 diabetes patients with comorbid dementia: a multicenter cohort study on 215,932 patients from the German/Austrian diabetes registry. Diabetes Res Clin Pract. 2016;112:73–81.PubMedCrossRef
21.
go back to reference Higuchi M, Chen R, Abbott RD, et al. Mid-life proteinuria and late-life cognitive function and dementia in elderly men: the Honolulu-Asia aging study. Alzheimer Dis Assoc Disord. 2015;29(3):200–5.PubMedPubMedCentralCrossRef Higuchi M, Chen R, Abbott RD, et al. Mid-life proteinuria and late-life cognitive function and dementia in elderly men: the Honolulu-Asia aging study. Alzheimer Dis Assoc Disord. 2015;29(3):200–5.PubMedPubMedCentralCrossRef
22.
go back to reference O'Hare AM, Walker R, Haneuse S, et al. Relationship between longitudinal measures of renal function and onset of dementia in a community cohort of older adults. J Am Geriatr Soc. 2012;60(12):2215–22.PubMedPubMedCentralCrossRef O'Hare AM, Walker R, Haneuse S, et al. Relationship between longitudinal measures of renal function and onset of dementia in a community cohort of older adults. J Am Geriatr Soc. 2012;60(12):2215–22.PubMedPubMedCentralCrossRef
23.
24.
go back to reference Miwa K, Tanaka M, Okazaki S, et al. Chronic kidney disease is associated with dementia independent of cerebral small-vessel disease. Neurology. 2014;82(12):1051–7.PubMedCrossRef Miwa K, Tanaka M, Okazaki S, et al. Chronic kidney disease is associated with dementia independent of cerebral small-vessel disease. Neurology. 2014;82(12):1051–7.PubMedCrossRef
25.
go back to reference Kurella Tamura M, Yaffe K, Hsu CY, et al. Cognitive impairment and progression of CKD. Am J kidney Dis. 2016;68(1):77–83.PubMedCrossRef Kurella Tamura M, Yaffe K, Hsu CY, et al. Cognitive impairment and progression of CKD. Am J kidney Dis. 2016;68(1):77–83.PubMedCrossRef
26.
go back to reference Murai S, Tanaka S, Dohi Y, Kimura G, Ohte N. The prevalence, characteristics, and clinical significance of abnormal albuminuria in patients with hypertension. Sci Rep. 2014;4:3884.PubMedPubMedCentralCrossRef Murai S, Tanaka S, Dohi Y, Kimura G, Ohte N. The prevalence, characteristics, and clinical significance of abnormal albuminuria in patients with hypertension. Sci Rep. 2014;4:3884.PubMedPubMedCentralCrossRef
27.
go back to reference Schrader J, Luders S, Kulschewski A, et al. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE study)*. J Hypertens. 2006;24(3):541–8.PubMedCrossRef Schrader J, Luders S, Kulschewski A, et al. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE study)*. J Hypertens. 2006;24(3):541–8.PubMedCrossRef
28.
go back to reference Georgakis MK, Dimitriou NG, Karalexi MA, et al. Albuminuria in association with cognitive function and dementia: a systematic review and meta-analysis. J Am Geriatr Soc. 2017;65(6):1190–8.PubMedCrossRef Georgakis MK, Dimitriou NG, Karalexi MA, et al. Albuminuria in association with cognitive function and dementia: a systematic review and meta-analysis. J Am Geriatr Soc. 2017;65(6):1190–8.PubMedCrossRef
29.
go back to reference Arvanitakis Z, Capuano AW, Leurgans SE, Bennett DA, Schneider JA. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol. 2016;15(9):934–43.PubMedPubMedCentralCrossRef Arvanitakis Z, Capuano AW, Leurgans SE, Bennett DA, Schneider JA. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol. 2016;15(9):934–43.PubMedPubMedCentralCrossRef
30.
go back to reference Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42(9):2672–713.PubMedPubMedCentralCrossRef Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42(9):2672–713.PubMedPubMedCentralCrossRef
32.
34.
go back to reference Yao H, Araki Y, Takashima Y, Uchino A, Yuzuriha T, Hashimoto M. Chronic kidney disease and subclinical brain infarction increase the risk of vascular cognitive impairment: the Sefuri study. J Stroke Cerebrovasc Dis. 2017;26(2):420–4.PubMedCrossRef Yao H, Araki Y, Takashima Y, Uchino A, Yuzuriha T, Hashimoto M. Chronic kidney disease and subclinical brain infarction increase the risk of vascular cognitive impairment: the Sefuri study. J Stroke Cerebrovasc Dis. 2017;26(2):420–4.PubMedCrossRef
35.
go back to reference Kurella Tamura M, Wadley V, Yaffe K, et al. Kidney function and cognitive impairment in US adults: the reasons for geographic and racial differences in stroke (REGARDS) study. Am J Kidney Dis. 2008;52(2):227–34.PubMedPubMedCentralCrossRef Kurella Tamura M, Wadley V, Yaffe K, et al. Kidney function and cognitive impairment in US adults: the reasons for geographic and racial differences in stroke (REGARDS) study. Am J Kidney Dis. 2008;52(2):227–34.PubMedPubMedCentralCrossRef
36.
go back to reference Stefani A, Sancesario G, Pierantozzi M, et al. CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia. J Neurol Sci. 2009;283(1–2):109–15.PubMedCrossRef Stefani A, Sancesario G, Pierantozzi M, et al. CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia. J Neurol Sci. 2009;283(1–2):109–15.PubMedCrossRef
Metadata
Title
Moderately increased albuminuria, chronic kidney disease and incident dementia: the HUNT study
Authors
Jessica Mira Gabin
Solfrid Romundstad
Ingvild Saltvedt
Jostein Holmen
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1425-8

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.